Skip to main content
. Author manuscript; available in PMC: 2013 Jan 18.
Published in final edited form as: Am J Psychiatry. 2012 Feb;169(2):160–166. doi: 10.1176/appi.ajp.2011.11030387

Table 2.

Trends in Stimulant Use in the U.S Population 18 Years and Younger, 1996–2008

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 1996–2008
Difference
2002–2008
Difference
1996–2002
Difference

t-stat p-value t-stat p-value t-stat p-value
Number of users (millions) 1.8 (1.4–2.2) 2.0 (1.7–2.3) 2.2 (1.8–2.6) 2.1 (1.7–2.6) 2.1 (1.6–2.7) 2.4 (2.0–2.8) 2.2 (1.9–2.6) 2.3 (2.0–2.7) 2.2 (1.8–2.6) 2.1 (2.1–2.9) 2.3 (1.7–2.4) 2.3 (1.9–2.7) 2.8 (2.3–3.2) 3.10 0.002 1.81 0.072 1.72 0.085
 0–5 0.1 (0.0–0.1) 0.1 (0.0–0.1) 0.1 (0.0–0.2) 0.1 (0.0–0.1) 0.1 (0.0–0.1) 0.1 (0.0–0.1) 0.1 (0.0–0.1) 0.1 (0.0–0.1) 0.0 (0.0–0.1) 0.0 (0.0–0.1) 0.0 (0.0–0.1) 0.0 (0.0–0.1) 0.0 (0.0–0.0) −1.14 0.256 −1.22 0.221 −0.04 0.967
 6–12 1.2 (0.9–1.5) 1.2 (1.0–1.5) 1.4 (1.0–1.7) 1.4 (1.0–1.7) 1.3 (0.9–1.6) 1.3 (1.1–1.6) 1.4 (1.1–1.6) 1.3 (1.0–1.5) 1.2 (0.9–1.4) 1.2 (0.9–1.4) 1.3 (1.0–1.6) 1.3 (1.1–1.6) 1.5 (1.2–1.8) 1.42 0.156 0.59 0.554 1.02 0.310
 13–18 0.5 (0.4–0.7) 0.7 (0.5–0.9) 0.7 (0.5–0.9) 0.7 (0.5–0.9) 0.8 (0.5–1.1) 0.9 (0.7–1.2) 0.8 (0.6–1.0) 1.0 (0.7–1.2) 1.0 (0.7–1.2) 0.8 (0.6–1.1) 1.0 (0.7–1.2) 1.0 (0.8–1.2) 1.3 (1.0–1.6) 3.93 <.001 2.57 0.010 2.06 0.040
Percent with Use 2.4 (1.8–2.9) 2.7 (2.3–3.1) 2.8 (2.3–3.3) 2.8 (2.3–3.3) 2.8 (2.3–3.3) 3.1 (2.6–3.5) 2.9 (2.5–3.3) 3.0 (2.6–3.5) 2.8 (2.4–3.3) 2.7 (2.3–3.1) 2.9 (2.5–3.4) 3.0 (2.5–3.5) 3.5 (3.0–4.1) 3.00 0.003 1.70 0.089 1.61 0.109
 0–5 0.3 (0.0–0.5) 0.4 (0.1–0.6) 0.4 (0.1–0.7) 0.3 (0.1–0.5) 0.3 (0.0–0.5) 0.4 (0.1–0.6) 0.3 (0.0–0.6) 0.3 (0.0–0.6) 0.1 (0.0–0.3) 0.1 (0.0–0.2) 0.1 (0.0–0.2) 0.1 (0.0–0.2) 0.1 (0.0–0.2) −1.18 0.238 −1.27 0.205 0.08 0.940
 6–12 4.2 (3.2–5.2) 4.4 (3.6–5.2) 4.8 (3.7–5.9) 4.7 (3.6–5.8) 4.4 (3.5–5.3) 4.7 (3.9–5.5) 4.8 (3.9–5.6) 4.4 (3.5–5.3) 4.1 (3.2–5.1) 4.2 (3.4–5.1) 4.7 (3.7–5.6) 4.6 (3.8–5.5) 5.1 (4.1–6.1) 1.29 0.197 0.54 0.591 0.89 0.373
 13–18 2.3 (1.5–3.1) 2.9 (2.2–3.7) 2.9 (2.0–3.8) 2.9 (2.1–3.7) 3.4 (2.4–4.4) 3.8 (2.9–4.7) 3.2 (2.6–3.9) 3.9 (3.0–4.8) 3.8 (2.8–4.8) 3.3 (2.5–4.1) 3.7 (2.8–4.6) 3.9 (3.0–4.8) 4.9 (3.9–6.1) 3.85 <.001 2.71 0.007 1.81 0.071
Total Population (millions) 75.3 75.6 76.5 76.7 76.7 77.0 77.0 77.2 77.3 77.4 78.4 78.3 79.0
 0–5 23.9 23.8 23.8 23.9 24.1 23.7 23.3 23.1 23.3 23.8 24.4 24.3 24.7
 6–12 27.9 28.3 28.4 29.3 28.5 28.5 28.6 28.7 28.2 27.9 28.0 28.3 28.9
 13–18 23.5 23.5 24.4 23.5 24 24.8 25.1 25.4 25.8 25.7 25.9 25.6 25.4
Sample Size 6,595 10,285 7,282 7,235 7,286 9,710 11,713 10,528 10,297 10,172 10,152 8,968 9,661
 0–5 2,018 3,081 2,116 2,158 2,221 2,924 3,455 3,194 3,177 3,114 3,103 2,674 3,046
 6–12 2,577 4,008 2,844 2,872 2,851 3,733 4,498 3,992 3,898 3,825 3,792 3,389 3,588
 13–18 2,000 3,196 2,322 2,205 2,214 3,053 3,760 3,342 3,222 3,233 3,257 2,905 3,027

Source: Authors’ Calculations from the Medical Expenditure Panel Survey (MEPS) 1996–2008